These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Next-Generation Sequencing of Endobronchial Ultrasound Transbronchial Needle Aspiration Specimens in Lung Cancer. Fielding D; Dalley AJ; Bashirzadeh F; Singh M; Nandakumar L; McCart Reed AE; Black D; Kazakoff S; Nones K; Pearson J; Waddell N; Lakhani SR; Simpson PT Am J Respir Crit Care Med; 2017 Aug; 196(3):388-391. PubMed ID: 28762784 [No Abstract] [Full Text] [Related]
67. Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC. Kim Y; Lee B; Shim JH; Lee SH; Park WY; Choi YL; Sun JM; Ahn JS; Ahn MJ; Park K J Thorac Oncol; 2019 Feb; 14(2):193-202. PubMed ID: 30391576 [TBL] [Abstract][Full Text] [Related]
69. Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database. Hanyok BT; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Posadas EM; Freedland SJ Cancer; 2016 Jan; 122(2):222-9. PubMed ID: 26484853 [TBL] [Abstract][Full Text] [Related]
70. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. Tetzlaff MT; Singh RR; Seviour EG; Curry JL; Hudgens CW; Bell D; Wimmer DA; Ning J; Czerniak BA; Zhang L; Davies MA; Prieto VG; Broaddus RR; Ram P; Luthra R; Esmaeli B J Pathol; 2016 Sep; 240(1):84-95. PubMed ID: 27287813 [TBL] [Abstract][Full Text] [Related]
71. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer. Sharp A; Coleman I; Yuan W; Sprenger C; Dolling D; Rodrigues DN; Russo JW; Figueiredo I; Bertan C; Seed G; Riisnaes R; Uo T; Neeb A; Welti J; Morrissey C; Carreira S; Luo J; Nelson PS; Balk SP; True LD; de Bono JS; Plymate SR J Clin Invest; 2019 Jan; 129(1):192-208. PubMed ID: 30334814 [TBL] [Abstract][Full Text] [Related]
72. Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C. Thysell E; Köhn L; Semenas J; Järemo H; Freyhult E; Lundholm M; Thellenberg Karlsson C; Damber JE; Widmark A; Crnalic S; Josefsson A; Welén K; Nilsson RJA; Bergh A; Wikström P Mol Oncol; 2022 Feb; 16(4):846-859. PubMed ID: 34889043 [TBL] [Abstract][Full Text] [Related]
73. Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer. Gupta S; Hovelson DH; Kemeny G; Halabi S; Foo WC; Anand M; Somarelli JA; Tomlins SA; Antonarakis ES; Luo J; Dittamore RV; George DJ; Rothwell C; Nanus DM; Armstrong AJ; Gregory SG Genes Chromosomes Cancer; 2020 Apr; 59(4):225-239. PubMed ID: 31705765 [TBL] [Abstract][Full Text] [Related]
74. Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving Kessel K; Seifert R; Weckesser M; Roll W; Humberg V; Schlack K; Bögemann M; Bernemann C; Rahbar K Theranostics; 2020; 10(17):7645-7655. PubMed ID: 32685010 [No Abstract] [Full Text] [Related]
75. Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer. Fettke H; Kwan EM; Docanto MM; Bukczynska P; Ng N; Graham LK; Mahon K; Hauser C; Tan W; Wang XH; Zhao Z; Zheng T; Zhou K; Du P; Yu J; Huang Y; Jia S; Kohli M; Horvath LG; Azad AA Eur Urol; 2020 Aug; 78(2):173-180. PubMed ID: 32487321 [TBL] [Abstract][Full Text] [Related]
76. Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer. Bray AW; Duan R; Malalur P; Drusbosky LM; Gourdin TS; Hill EG; Lilly MB Prostate; 2022 Sep; 82(13):1264-1272. PubMed ID: 35766303 [TBL] [Abstract][Full Text] [Related]
77. Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. Hussain M; Daignault-Newton S; Twardowski PW; Albany C; Stein MN; Kunju LP; Siddiqui J; Wu YM; Robinson D; Lonigro RJ; Cao X; Tomlins SA; Mehra R; Cooney KA; Montgomery B; Antonarakis ES; Shevrin DH; Corn PG; Whang YE; Smith DC; Caram MV; Knudsen KE; Stadler WM; Feng FY; Chinnaiyan AM J Clin Oncol; 2018 Apr; 36(10):991-999. PubMed ID: 29261439 [TBL] [Abstract][Full Text] [Related]
78. Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer. Gupta S; Li J; Kemeny G; Bitting RL; Beaver J; Somarelli JA; Ware KE; Gregory S; Armstrong AJ Clin Cancer Res; 2017 Mar; 23(5):1346-1357. PubMed ID: 27601596 [No Abstract] [Full Text] [Related]
79. Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer. Saylor PJ; Lee RJ; Arora KS; Deshpande V; Hu R; Olivier K; Meneely E; Rivera MN; Ting DT; Wu CL; Miyamoto DT Clin Cancer Res; 2017 Jan; 23(2):363-369. PubMed ID: 27440270 [TBL] [Abstract][Full Text] [Related]
80. Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects. Isaacsson Velho P; Qazi F; Hassan S; Carducci MA; Denmeade SR; Markowski MC; Thorek DL; DeWeese TL; Song DY; Tran PT; Eisenberger MA; Antonarakis ES Eur Urol; 2019 Aug; 76(2):170-176. PubMed ID: 30293905 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]